| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |